Neptune Wellness Solutions (NASDAQ:NEPT) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) in a note issued to investors on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock.

Neptune Wellness Solutions Price Performance

The stock’s fifty day simple moving average is $0.39 and its 200-day simple moving average is $3.12. Neptune Wellness Solutions has a 12-month low of $0.19 and a 12-month high of $28.00. The stock has a market capitalization of $906,000.00, a P/E ratio of 0.00 and a beta of 2.19.

Insider Buying and Selling

In related news, major shareholder Securities Settlement Neptune sold 64,819 shares of the stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $0.44, for a total transaction of $28,520.36. Following the transaction, the insider now directly owns 1,738,116 shares in the company, valued at $764,771.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 5.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Neptune Wellness Solutions

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Stifel Financial Corp acquired a new stake in Neptune Wellness Solutions during the first quarter worth about $41,000. Morgan Stanley increased its stake in Neptune Wellness Solutions by 26,898.7% during the fourth quarter. Morgan Stanley now owns 544,833 shares of the biotechnology company’s stock worth $172,000 after acquiring an additional 542,815 shares during the last quarter. Citadel Advisors LLC acquired a new stake in Neptune Wellness Solutions during the third quarter worth about $43,000. Renaissance Technologies LLC increased its stake in Neptune Wellness Solutions by 12.6% during the third quarter. Renaissance Technologies LLC now owns 128,684 shares of the biotechnology company’s stock worth $196,000 after acquiring an additional 14,395 shares during the last quarter. Finally, Virtu Financial LLC increased its stake in Neptune Wellness Solutions by 257.6% during the first quarter. Virtu Financial LLC now owns 554,376 shares of the biotechnology company’s stock worth $123,000 after acquiring an additional 399,362 shares during the last quarter. 14.44% of the stock is currently owned by institutional investors and hedge funds.

Neptune Wellness Solutions Company Profile

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.